363 related articles for article (PubMed ID: 33324248)
1. Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis?
Rovný R; Besterciová D; Riečanský I
Front Psychiatry; 2020; 11():550225. PubMed ID: 33324248
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating.
Quednow BB; Brinkmeyer J; Mobascher A; Nothnagel M; Musso F; Gründer G; Savary N; Petrovsky N; Frommann I; Lennertz L; Spreckelmeyer KN; Wienker TF; Dahmen N; Thuerauf N; Clepce M; Kiefer F; Majic T; Mössner R; Maier W; Gallinat J; Diaz-Lacava A; Toliat MR; Thiele H; Nürnberg P; Wagner M; Winterer G
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6271-6. PubMed ID: 22451930
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis on the association between genetic polymorphisms and prepulse inhibition of the acoustic startle response.
Quednow BB; Ejebe K; Wagner M; Giakoumaki SG; Bitsios P; Kumari V; Roussos P
Schizophr Res; 2018 Aug; 198():52-59. PubMed ID: 29287625
[TBL] [Abstract][Full Text] [Related]
4. The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers.
Quednow BB; Ettinger U; Mössner R; Rujescu D; Giegling I; Collier DA; Schmechtig A; Kühn KU; Möller HJ; Maier W; Wagner M; Kumari V
J Neurosci; 2011 May; 31(18):6684-91. PubMed ID: 21543597
[TBL] [Abstract][Full Text] [Related]
5. Association study of polymorphisms in the alpha 7 nicotinic acetylcholine receptor subunit and catechol-o-methyl transferase genes with sensory gating in first-episode schizophrenia.
Liu X; Hong X; Chan RC; Kong F; Peng Z; Wan X; Wang C; Cheng L
Psychiatry Res; 2013 Oct; 209(3):431-8. PubMed ID: 23598060
[TBL] [Abstract][Full Text] [Related]
6. Association Study of CHRNA7 Promoter Variants with Sensory and Sensorimotor Gating in Schizophrenia Patients and Healthy Controls: A Danish Case-Control Study.
Bertelsen B; Oranje B; Melchior L; Fagerlund B; Werge TM; Mikkelsen JD; Tümer Z; Glenthøj BY
Neuromolecular Med; 2015 Dec; 17(4):423-30. PubMed ID: 26376812
[TBL] [Abstract][Full Text] [Related]
7. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder.
Cadenhead KS; Light GA; Geyer MA; Braff DL
Am J Psychiatry; 2000 Jan; 157(1):55-9. PubMed ID: 10618013
[TBL] [Abstract][Full Text] [Related]
8. Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.
Petrovsky N; Quednow BB; Ettinger U; Schmechtig A; Mössner R; Collier DA; Kühn KU; Maier W; Wagner M; Kumari V
Neuropsychopharmacology; 2010 Jun; 35(7):1429-39. PubMed ID: 20393456
[TBL] [Abstract][Full Text] [Related]
9. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.
Cadenhead KS; Geyer MA; Braff DL
Am J Psychiatry; 1993 Dec; 150(12):1862-7. PubMed ID: 8238643
[TBL] [Abstract][Full Text] [Related]
10. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
Riba J; Rodríguez-Fornells A; Barbanoj MJ
Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
[TBL] [Abstract][Full Text] [Related]
11. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
[TBL] [Abstract][Full Text] [Related]
13. Association between genetic variability of neuronal nitric oxide synthase and sensorimotor gating in humans.
Rovný R; Marko M; Katina S; Murínová J; Roháriková V; Cimrová B; Repiská G; Minárik G; Riečanský I
Nitric Oxide; 2018 Nov; 80():32-36. PubMed ID: 30096361
[TBL] [Abstract][Full Text] [Related]
14. Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.
Hall MH; Taylor G; Salisbury DF; Levy DL
Schizophr Bull; 2011 Nov; 37(6):1187-99. PubMed ID: 20363872
[TBL] [Abstract][Full Text] [Related]
15. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.
Swerdlow NR; Geyer MA; Shoemaker JM; Light GA; Braff DL; Stevens KE; Sharp R; Breier M; Neary A; Auerbach PP
Neuropsychopharmacology; 2006 Mar; 31(3):506-15. PubMed ID: 16123772
[TBL] [Abstract][Full Text] [Related]
16. Prepulse inhibition of the acoustic startle reflex and P50 gating in aging and alzheimer's disease.
Jafari Z; Kolb BE; Mohajerani MH
Ageing Res Rev; 2020 May; 59():101028. PubMed ID: 32092463
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans.
Mann C; Croft RJ; Scholes KE; Dunne A; O'Neill BV; Leung S; Copolov D; Phan KL; Nathan PJ
Neuropsychopharmacology; 2008 Jun; 33(7):1653-66. PubMed ID: 17895917
[TBL] [Abstract][Full Text] [Related]
18. Effects of methylphenidate on sensory and sensorimotor gating of initially psychostimulant-naïve adult ADHD patients.
Sommer JL; Low AM; Jepsen JRM; Fagerlund B; Vangkilde S; Habekost T; Glenthøj B; Oranje B
Eur Neuropsychopharmacol; 2021 May; 46():83-92. PubMed ID: 33663902
[TBL] [Abstract][Full Text] [Related]
19. Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval.
Hong LE; Summerfelt A; Wonodi I; Adami H; Buchanan RW; Thaker GK
Am J Psychiatry; 2007 Jan; 164(1):61-5. PubMed ID: 17202545
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
